Live networks in care production with the user at the center of the treatment for multidrug-resistant tuberculosis

被引：0

作者：

Leung, Janaina Aparecida de Medeiros ^{[1
]}

Cunha, Fatima Teresinha Scarparo ^{[2
]}

Merhy, Emerson Elias ^{[3
]}

Kritski, Afranio Lineu ^{[4
]}

机构：

[1] Univ Fed Rio de Janeiro UFRJ, Fac Med FM, Posgrad Programa Posgrad Clin Med, Rua Prof Rodolpho Paulo Rocco 255,1 Andar,Sala 01D, BR-21941913 Rio De Janeiro, RJ, Brazil

[2] Univ Fed Rio de Janeiro, Escola Enfermagem Alfredo Pinto, Dept Enfermagem Saude Publ, Rio de Janeiro, RJ, Brazil

[3] UFRJ, Inst Ciencias Med, Ctr Multidisciplinar, Dept Saude Colet Mental & Familia, Macae, RJ, Brazil

[4] Univ Fed Rio de Janeiro, FM, Programa Acad TB, Rio de Janeiro, RJ, Brazil

来源：

INTERFACE-COMUNICACAO SAUDE EDUCACAO | 2024年 / 28卷

关键词：

Tuberculosis; Multidrug-resistant tuberculosis; Patient-centered care; Life-changing events; Community-based networks; PEOPLE;

D O I：

10.1590/interface.230439

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We followed the trajectory of a guiding user undergoing treatment for multidrug-resistant tuberculosis (MDR-TB). The narratives of Live Networks in care production showed: 1) Caring in the act of living: Overcoming stigmas and cultivating bonds that help overcome discourses fostered by fear, prejudice, exclusion and invisibility of subjects; 2) Live Networks of care: The in-betweens of the norm; and 3) Interfaces of user-health worker care: How can we demystify the judgment of health workers who, subordinated to limiting protocols, often stigmatize the user as someone who "abandons the treatment"? The guiding user perceived that caring means deterritorializing oneself, expressing one's desires as power for transformation, and leaving the modus operandi towards creativity, with the user at the center of the process.

引用

页数：15

共 50 条

[41] Multidrug-resistant tuberculosis
Seaworth, BJ
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (01) : 73 - +
[42] Reducing harm in the treatment of multidrug-resistant tuberculosis
Reuter, Anja
Furin, Jennifer
LANCET, 2018, 392 (10150): : 797 - 798
[43] QTc prolongation and treatment of multidrug-resistant tuberculosis
Harausz, E.
Cox, H.
Rich, M.
Mitnick, C. D.
Zimetbaum, P.
Furin, J.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (04) : 385 - 391
[44] An Update On The Trends And Treatment In Multidrug-Resistant Tuberculosis
Reynolds, I. R.
Chan, E. D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
[45] Programmes and principles in treatment of multidrug-resistant tuberculosis
Mukherjee, JS
Rich, ML
Socci, AR
Joseph, JK
Virú, FA
Shin, SS
Furin, JJ
Becerra, MC
Barry, DJ
Kim, JY
Bayona, J
Farmer, P
Fawzi, MCS
Seung, KJ
LANCET, 2004, 363 (9407): : 474 - 481
[46] Clofazimine as a Treatment for Multidrug-Resistant Tuberculosis: A Review
Nugraha, Rhea Veda
Yunivita, Vycke
Santoso, Prayudi
Aarnoutse, Rob E.
Ruslami, Rovina
SCIENTIA PHARMACEUTICA, 2021, 89 (02)
[47] Treatment of Multidrug-Resistant Tuberculosis in Children and Adolescents
Chiang, Silvia S.
Furin, Jennifer J.
JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2018, 13 (02) : 153 - 167
[48] More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
Brust, James C. M.
Shah, N. Sarita
Gandhi, Neel R.
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26): : 2610 - 2610
[49] Aggressive surgical treatment of multidrug-resistant tuberculosis
Shiraishi, Yuji
Katsuragi, Naoya
Kita, Hidefumi
Tominaga, Yoshiaki
Kariatsumari, Kota
Onda, Takato
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2009, 138 (05): : 1180 - 1184
[50] Changes in treatment outcomes of multidrug-resistant tuberculosis
Kwak, N.
Kim, H-R.
Yoo, C-G.
Kim, Y. W.
Han, S. K.
Yim, J-J.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (06) : 708 - 708

← 1 2 3 4 5 →